GGrantIndex
Sort

48,018 grants matching immunotherapy

Preclinical GEM and GDA Models of Primary and Metastatic Melanoma

$1,323,540
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

CO17 1A/GA733 ANTIGEN IN COLORECTAL CANCER THERAPY

$1,320,582
Wistar Institute · P01 · FY2002 · CA

Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression

$1,318,085
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response

$1,318,085
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases

$1,317,817
Chi-Chao Chan · National Eye Institute · Z01 · FY2008 · EY

MACROPHAGE-CENTRIC PROGNOSTIC BIOMARKERS FOR CHECKPOINT BLOCKADE IMMUNOTHERAPY IN MELANOMA

$1,317,584
University Of Alabama At Birmingham · · FY2025 · Defense Health Agency

Autonomic Disorders Programs Project

$1,316,875
Mayo Clinic · P50 · FY2005 · NS

Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas

$1,316,832
Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2018 · CA

Heat Shock Protein and Thermal Therapy of Cancer

$1,316,642
Roswell Park Cancer Institute Corp · P01 · FY2003 · CA

Autonomic Disorders Programs Project

$1,316,574
Phillip A Low · Mayo Clinic Rochester · P50 · FY2006 · NS

Administrative Core

$1,316,277
Jinming Gao · Ut Southwestern Medical Center · U54 · FY2019 · CA

Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas

$1,316,276
Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2020 · CA

Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas

$1,316,194
Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2021 · CA

Immunotherapy to prevent drug-resistant tuberculosis

$1,315,804
Rhea N Coler · Access To Advanced Health Institute · R01 · FY2016 · AI

CAP-IT Center for LNP RNA Immunoprevention

$1,315,413
Vivek Mittal · Weill Medical Coll Of Cornell Univ · U54 · FY2025 · CA

Role of co-receptor modified cells in HIV infection

$1,314,844
Carl H. June · University Of Pennsylvania · U01 · FY2013 · AI

The cBioPortal for Cancer Genomics

$1,314,519
Nikolaus Schultz · Sloan-Kettering Inst Can Research · U24 · FY2017 · CA

Immunotherapy to prevent drug-resistant tuberculosis

$1,314,028
Rhea N Coler · Access To Advanced Health Institute · R01 · FY2017 · AI

Innovations in Functional B Cell Epitope Discovery for Food Allergy

$1,313,458
Scott Boyd · Stanford University · N01 · FY2024 · AI

Development of new antibody-based cancer therapies

$1,311,816
Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Regulation of innate lymphocyte function

$1,311,736
Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana

$1,311,671
Roger L Shapiro · Harvard University D/B/A Harvard School Of Public Health · U01 · FY2025 · AI

PEDIATRIC AIDS CLINICAL TRIALS UNIT

$1,310,981
Children'S Memorial Hospital (Chicago) · U01 · FY2001 · AI

Role of the microbiota in regulating the mononuclear phagocyte system

$1,310,229
Silvana Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Human Mab Cocktails to Prevent & Treat H5N1 Avian Influenza

$1,309,684
Wayne A. Marasco · Dana-Farber Cancer Inst · U01 · FY2009 · AI